Neuropsychiatria Przegląd Kliniczny
Latest Publications


TOTAL DOCUMENTS

20
(FIVE YEARS 0)

H-INDEX

0
(FIVE YEARS 0)

Published By Medical Education

2084-2619, 2080-4091

2020 ◽  
Vol 12 (1-2) ◽  
pp. 12-17
Author(s):  
Janusz Szeluga ◽  
Piotr Pankiewicz ◽  
Rafał Miętkiewicz

The position of court psychiatry, or that of a psychiatrist in the society, is linked to the social attitude to persons who are mentally ill. Currently, we see a change in the traditional perception of the role of psychiatry and the image of a psychiatrist in the society. It must be highlighted that the process involves the whole medical profession; however, psychiatrists are at the forefront. It is difficult to understand the causes of opinions without looking at the history.


2020 ◽  
Vol 12 (1-2) ◽  
pp. 18-21
Author(s):  
Konrad Jurczakowski

This article presents a case of a patient, which shows that there is an interaction between cigarette smoking and duloxetine metabolism and how this connection can affect treatment efficacy.


2020 ◽  
Vol 12 (1-2) ◽  
pp. 22-29
Author(s):  
Bartosz Łoza

Doctors belong to the professional group most experienced by burnout, chronic fatigue and depression syndromes. Experiencing the pandemic crisis further increases the risk of stress and possible decompensation. The publication discusses the cognitive-behavioral aspects of coping with the current situation by doctors. It indicates the sources of stress, the importance of individual threats and distinguishes between effective and ineffective strategies for dealing with stress.


2020 ◽  
Vol 12 (1-2) ◽  
pp. 5-11
Author(s):  
Bartosz Łoza

The limited effectiveness of anti-addiction pharmacotherapy encourages the introduction of so called harm reduction programs. They allow you to significantly reduce the health, social and economic damages of addicts and their families. The simplest form of harm reduction is the substitution therapy. You can use the same psychoactive substance (e.g. nicotine in patches) or give a different one (e.g. methadone vs morphine). Harm reduction programs are typically criticized for allegedly extending the addiction period. However, the experience of many countries shows that they are effectively contributing to recovery from addiction. Considering the fact that smoking is the main modifiable cause of diseases, and at the same time that there are no sufficiently effective methods of treating this addiction, the use of harm reduction programs – based on the so-called novel tobacco products – seems to be the most appropriate choice. Precedent registrations of subsequent Modified Risk Tobacco Products in the US create conditions to pragmatically replace tobacco products in which smoking occurs – other, smokeless, and at the same time less harmful.


2019 ◽  
Vol 11 (3-4) ◽  
pp. 61-69
Author(s):  
Maja Herman ◽  
Bartosz Łoza
Keyword(s):  

2019 ◽  
Vol 11 (3-4) ◽  
pp. 41-50
Author(s):  
Bartosz Łoza ◽  
Karina Jahnz-Różyk ◽  
Dorota Karkowska ◽  
Wojciech Kozubski ◽  
Artur Mamcarz ◽  
...  

2019 ◽  
Vol 11 (3-4) ◽  
pp. 55-60
Author(s):  
Zuzanna Dylewska ◽  
Ondrasz Kąkol ◽  
Radosława Kompowska-Marek ◽  
Aleksandra Chmielnicka-Plaskota

2019 ◽  
Vol 11 (1-2) ◽  
pp. 18-21
Author(s):  
Maja Herman ◽  
Bartosz Łoza
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document